Indian generic drug manufacturers play a critical role in supplying medicines to global markets, but demand volatility, cost pressures, and complex partner ecosystems make supply chain performance increasingly challenging. Competing globally requires manufacturers to balance inventory, cost, service, and supply reliability while gaining greater visibility across end-to-end operations.
In this video interview series, Anand Modi, VP of Sales, India at TraceLink, explains how supply chain digitalization can help manufacturers link systems and trading partners, improve order and shipment visibility, and respond faster as supply conditions change.
Modi also explains why digital maturity and clean data are essential for AI adoption as companies look to improve efficiency and respond to growing supply chain demands. This digital foundation is also a critical component for companies adopting the Agentic Supply Chain Operating Model, where humans and governed AI agents work together to improve supply chain productivity and business performance.
What Supply Chain Challenges Are Indian Generic Drug Manufacturers Facing Today?
How Can Indian Drug Manufacturers Provide Better Order Visibility to Customers?
What Capability Do Drug Manufacturers Need to Gain End-to-End Supply Chain Visibility?
Why Do Pharmaceutical Companies Need an Industrial-Grade Supply Chain Platform?
Why Is Supply Chain Digitalization Essential for AI Adoption?
